Cambridge Investment Research Advisors’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,724
Closed -$274K 3141
2022
Q2
$274K Sell
5,724
-145
-2% -$6.72K ﹤0.01% 2458
2022
Q1
$310K Sell
5,869
-156
-3% -$8.21K ﹤0.01% 2522
2021
Q4
$309K Buy
6,025
+1,536
+34% +$90.6K ﹤0.01% 2504
2021
Q3
$299K Sell
4,489
-258
-5% -$20.2K ﹤0.01% 2472
2021
Q2
$436K Buy
4,747
+2,504
+112% +$247K ﹤0.01% 2163
2021
Q1
$273K Buy
2,243
+182
+9% +$30.3K ﹤0.01% 2346
2020
Q4
$316K Buy
+2,061
New +$291K ﹤0.01% 2091

Other funds holding PRLB

Cambridge Investment Research Advisors's PRLB Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Protolabs (PRLB) in Q3 2022, closing a stake of 5,724 shares — an estimated $274K sold.

Cambridge Investment Research Advisors first reported a position in PRLB in Q4 2020 and held it in 7 quarters. The position peaked at $436K in Q2 2021. 211 funds tracked by Wall St. Rank hold PRLB as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Protolabs position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,724 Protolabs shares in Q3 2022, an estimated $274K.
  • Cambridge Investment Research Advisors first reported a position in Protolabs in Q4 2020 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Protolabs position peaked at $436K in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Protolabs as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.